معرفی
Dr. Lucianne Groenink is an Associate Professor of Psychopharmacology at Utrecht University's Faculty of Science. She serves as Principal Investigator at the Utrecht Institute of Pharmaceutical Sciences (UIPS) and is an affiliated partner of the UMC Brain Center Utrecht. With over 15 years of continuous academic service since 2007, she has established herself as a leading researcher in psychoneuroimmunopharmacology and methodological approaches to enhance research quality.
Her research interests focus on anxiety pharmacology, neuroscience, psychopharmacology, and animal models of psychiatric disorders, with particular emphasis on neuro-immune interactions. Groenink's work integrates systematic reviews, meta-analyses, and advanced data synthesis techniques to improve drug development processes for psychiatric conditions. Her innovative approach applies adverse outcome pathway (AOP)-like network methodologies to identify potential drug targets and improve research quality.
Analysis of her recent publications (2021-2025) reveals a consistent focus on systematic approaches to psychopharmacology, with particular emphasis on cannabinoid research, SSRIs, fear learning mechanisms, and neuro-immune interactions. Her work demonstrates strong translational value, bridging preclinical animal studies with clinical applications while addressing methodological challenges in the field.
- Registered Pharmacologist (Dutch Pharmacology Society)
- Fellow member of the European College of Neuropsychopharmacology
- Ambassador of SYRCLE (Systematic Review Centre for Laboratory animal Experimentation)
- Senior research qualification (SKO, since 2007)
- Certified Pharmacologist (since 2012)
As an educator, Groenink serves as Programme coordinator of the College of Pharmaceutical Sciences (CPS), a three-year international Bachelor's program. She mentors numerous graduate students across various research projects and has secured substantial funding from national organizations (NWO, ZonMW) and pharmaceutical industries (Servier, Grunenthal, Abbvie, Neurolixis, Nutricia Research). Her research group actively collaborates with immunopharmacology and experimental pharmacology teams within Utrecht University's Pharmacology division.
Groenink's laboratory focuses on integrating existing pharmacological data through machine learning and meta-analyses to identify novel drug targets and generate maps for complex physiological systems. Her work significantly contributes to defining best practices for animal studies and informing human research in psychopharmacology.